Company: MDXG
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001376339-25-000048
Chunk: 1

Company: MIMEDX GROUP, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 1
---
 | To approve, on an advisory basis, the Company’s executive compensation (Proposal 2);                                                                                       |
| (3) |     | To ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025 (Proposal 3); |
| (4) |     | To approve the amendment of the Company’s 2016 Equity and Cash Incentive Plan to increase the number of shares available (Proposal 4);                                     |
| (5) |     | To approve, on an advisory basis, the frequency of the shareholder vote on the Company’s executive compensation (Proposal 5); and                                          |
| (6) |     | To transact such other business as may properly come before the Annual Meeting or any adjournment or any postponement thereof.                                             |

The Board has fixed 5:00 p.m. Eastern time on April 21, 2025 as the record date for determining those shareholders who will be entitled to notice of, and to vote at, the Annual Meeting. The Annual Meeting will be conducted in virtual format only (as described in the notice of annual meeting) in order to provide access to our shareholders regardless of geographic location. There is no in-person meeting for you to attend.

THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR THE ELECTION OF THE BOARD’S NOMINEES AND FOR EACH OF THE OTHER PROPOSALS TO BE CONSIDERED AT THE ANNUAL MEETING USING THE ENCLOSED PROXY CARD OR VOTING INSTRUCTION FORM, AS APPLICABLE.

It is extremely important that your shares be represented and voted at the Annual Meeting. Please vote as soon as possible. You are urged to sign, date, and return the proxy card or voting instruction form, as applicable, in the postage-paid envelope provided to you, or to use the Internet or telephone method of voting described on your proxy card or voting instruction form, as applicable.

If you have any question or need any assistance in voting your shares, please contact the Company’s Head of Investor Relations: Matt Notarianni at 470-304-7291 or mnotarianni@mimedx.com or Broadridge at 844-986-0822 (U.S.) or 303-562-9032 (International).

| Sincerely,                           |
| /s/ M. Kathleen Behrens              |
| M. Kathleen Behrens                  |
| Chairperson of